Adimmune Corp Cash Flow Reinvestment Rate
Adimmune Corp cash flow reinvestment rate. Adimmune Corp (4142) has a Cash Flow Reinvestment Rate of 0.09x as of December 2024, reinvesting NT$62.47 Million (capex NT$42.60 Million plus investments NT$19.87 Million) from operating cash flow of NT$658.32 Million. Explore cash flow to debt ratio of Adimmune Corp to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Adimmune Corp (2007–2024)
Cash flow reinvestment rate of Adimmune Corp from 2007 to 2024. Historical reinvestment intensity for Adimmune Corp across 6 annual periods. Explore 4142 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Adimmune Corp Cash Flow Reinvestment Rate by Year (2007–2024)
Adimmune Corp cash flow reinvestment rate by year from 2007 to 2024. Year-by-year capital reinvestment analysis for Adimmune Corp. For the full cash flow conversion analysis, see Adimmune Corp (4142) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.38x | NT$256.18 Million | NT$668.48 Million | NT$155.22 Million | ▲ +72.2% |
| 2020 | 0.22x | NT$516.76 Million | NT$2.32 Billion | NT$218.30 Million | ▼ -99.6% |
| 2017 | 61.73x | NT$424.37 Million | NT$6.87 Million | NT$11.35 Million | ▲ +4990.1% |
| 2010 | 1.21x | NT$626.30 Million | NT$516.39 Million | NT$626.30 Million | ▲ +3.5% |
| 2009 | 1.17x | NT$703.82 Million | NT$600.42 Million | NT$703.82 Million | ▼ -86.2% |
| 2007 | 8.50x | NT$265.77 Million | NT$31.26 Million | NT$265.77 Million | — |